Fig. 1. Yearly proportions (A) and annual numbers (B) of patients receiving TACE as the initial treatment plan (TACE_initial), TACE in TARE-ineligible patients (TACE_{high LSF}), and TARE between 2010 and 2023. TACE = transarterial chemoembolization, TARE = transarterial radioembolization, LSF = lung shunt fraction.